Lv4
430 积分 2025-12-14 加入
Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial
1天前
已完结
Survival outcomes of human epidermal growth factor receptor 2 (HER2)–amplified and HER2-mutated left-sided colorectal cancer (CRC) patients treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs)
3天前
已完结
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
7天前
已完结
Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer
14天前
已完结
Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer
15天前
已完结
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
4个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
10个月前
已完结
Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
10个月前
已完结
皖公网安备34019202002308
